Bitcoin briefly fell below $74,000 due to concerns over an internal investigation at Nvidia and stalled US-Iran talks, before quickly rebounding above $75,000. These events spooked investors by raising geopolitical and corporate governance risks, triggering over $1 billion in liquidations, mostly on bullish crypto positions. The crypto market acted as an early risk barometer while traditional markets were closed, showing heightened volatility due to low liquidity and leverage. Going forward, Bitcoin remains sensitive to external news, with price swings expected between key moving averages as investors react to global developments.
Bitcoin price moves provide context for cryptocurrency market trends. For readers following crypto, here is Pluang's market snapshot as of Nov 09, 2026 21:02 WIB: Out of 50 major cryptocurrencies, 19 rose and 29 fell today. Notable movers include SXP down 46.27%, ONE down 18.22% with a 51% sell order activity, and BAL up 11.14%. Typical hold times range from 85 to 153 days.
More News
Neo launches Neoverse, a free AI security engine analyzing 4M+ AI apps to block malicious software automatically.
Neo Security, Inc. has launched Neoverse, a free AI software intelligence engine that researches and classifies over 4 million AI apps, extensions, and servers to assess their capabilities and security risks. Integrated into Neo's platform, Neoverse ...
AnorTech closes $7.55M share exchange, Greenland Mines now owns 19.9% stake
AnorTech Inc. completed a $7.55 million share exchange with Nasdaq-listed Greenland Mines, increasing Greenland Mines' ownership in AnorTech to 19.9%. Greenland Mines acquired over 25 million AnorTech shares in exchange for Greenland Mines shares val...
Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
